OFI Invest Asset Management’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Buy
7,802
+266
+4% +$12.3K ﹤0.01% 333
2026
Q1
$287K Sell
7,536
-1,392
-16% -$63.5K ﹤0.01% 306
2025
Q4
$337K Sell
8,928
-285
-3% -$12.3K ﹤0.01% 306
2025
Q3
$331K Sell
9,213
-1,475
-14% -$59.5K 0.01% 194
2025
Q2
$334K Buy
10,688
+48
+0.5% +$1.78K 0.01% 191
2025
Q1
$375K Sell
10,640
-550
-5% -$20.5K 0.01% 247
2024
Q4
$409K Buy
+11,190
New +$447K 0.01% 245
2024
Q2
$377K Hold
11,810
0.01% 238
2024
Q1
$346K Sell
11,810
-1,442
-11% -$43.8K 0.01% 154
2023
Q4
$368K Sell
13,252
-2,932
-18% -$94.1K 0.01% 154
2023
Q3
$507K Sell
16,184
-1,075
-6% -$34.3K 0.02% 127
2023
Q2
$530K Sell
17,259
-460,854
-96% -$13.3M 0.02% 90
2023
Q1
$17.4M Buy
+478,113
New +$13.3M 0.09% 79

Other funds holding OHI

OFI Invest Asset Management's OHI Position: Q2 2026 in Review

OFI Invest Asset Management increased its Omega Healthcare (OHI) stake by 3.5% in Q2 2026, buying an estimated $12.3K and bringing the position to 7,802 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

OFI Invest Asset Management first reported a position in OHI in Q1 2023 and has held it in 13 quarters since. The position peaked at $17.4M in Q1 2023. 442 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • OFI Invest Asset Management held 7,802 shares of Omega Healthcare worth $325K as of Q2 2026.
  • OFI Invest Asset Management bought 266 Omega Healthcare shares in Q2 2026, an estimated $12.3K.
  • Omega Healthcare made up ﹤0.01% of OFI Invest Asset Management's portfolio in Q2 2026, its #333 holding.
  • OFI Invest Asset Management first reported a position in Omega Healthcare in Q1 2023 and has held it in 13 quarters since.
  • OFI Invest Asset Management's Omega Healthcare position peaked at $17.4M in Q1 2023.
  • 442 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.